Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14440540 | 1.00 | ALDH1A1 (0.43) | ALDH1A1GAAL3MBTL1TSHRBCHE | |
| SCHEMBL14440928 | 1.00 | ALDH1A1 (0.43) | ALDH1A1GAAL3MBTL1TSHRBCHE | |
| SCHEMBL14568965 | 1.00 | ALDH1A1 (0.43) | ALDH1A1GAAL3MBTL1TSHRBCHE | |
| SCHEMBL7902263 | 0.89 | L3MBTL1 (0.41) | ALDH1A1GAAL3MBTL1TSHRBCHE | |
| SCHEMBL7902115 | 0.85 | TSHR (0.34) | ALDH1A1GAAL3MBTL1TSHRBCHE | |
| SCHEMBL17773534 | 0.83 | PTGES2 (0.41) | ALDH1A1GAATSHRBCHEABCB1 | |
| SCHEMBL7932128 | 0.81 | ALDH1A1 (0.38) | ALDH1A1GAAL3MBTL1TSHRBCHE | |
| SCHEMBL7150011 | 0.80 | ALDH1A1 (0.46) | ALDH1A1GAAL3MBTL1TSHRBCHE | |
| SCHEMBL9293649 | 0.79 | ALDH1A1 (0.54) | ALDH1A1GAATSHRBCHEABCB1 | |
| SCHEMBL14215488 | 0.79 | ALDH1A1 (0.54) | ALDH1A1GAATSHRBCHEABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185063-A1 | Seven-membered ring nucleosides | IDENIX PHARMACEUTICALS, INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070185063-A1 | Seven-membered ring nucleosides | IDENIX PHARMACEUTICALS, INC. | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185063-A1 | Seven-membered ring nucleosides | NSUN2, NSUN3, HAVCR2 | ALDH1A1 2563/4885GAA 1398/4885L3MBTL1 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.